Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

TAVR for All? The Surgical Perspective

Publikation: Bidrag til tidsskriftReviewpeer review


  1. Transcatheter aortic valve-in-valve implantation to treat aortic Para-valvular regurgitation after TAVI

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Management and Outcome of Acute Ischemic Stroke Complicating Transcatheter Aortic Valve Replacement

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Coronary Access Following Redo TAVR: Impact of THV Design, Implant Technique, and Cell Misalignment

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  • Xiling Zhang
  • Thomas Puehler
  • Derk Frank
  • Janarthanan Sathananthan
  • Stephanie Sellers
  • David Meier
  • Marcus Both
  • Philipp Blanke
  • Hatim Seoudy
  • Mohammed Saad
  • Oliver J Müller
  • Lars Sondergaard
  • Georg Lutter
Vis graf over relationer

In spite of the noninferiority of transcatheter aortic valve replacement (TAVR) in high- and intermediate-risk patients, there are still obstacles that need to be overcome before the procedure is further expanded and clinically integrated. The lack of evidence on the long-term durability of the bioprostheses used for TAVR remains of particular concern. In addition, surgery may be preferred over TAVR in patients with bicuspid aortic valve (BAV) or with concomitant pathologies such as other valve diseases (mitral regurgitation/tricuspid regurgitation), aortopathy, and coronary artery disease. In this review, we discuss and summarize relevant data from clinical trials, current trends, and remaining obstacles, and provide our perspective on the indications for the expansion of TAVR.

TidsskriftJournal of cardiovascular development and disease
Udgave nummer7
StatusUdgivet - 12 jul. 2022

ID: 79704845